Page last updated: 2024-09-05

sorafenib and Choroid Neovascularization

sorafenib has been researched along with Choroid Neovascularization in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abbate, I; Apicella, I; Bucolo, C; D'Agata, V; De Falco, S; Giuliano, F; La Rosa, LR; Maugeri, G; Mazzone, MG; Platania, CBM; Santonocito, M; Solfato, E; Tarallo, V; Viola, S; Zappulla, C1
Liu, YL; Wang, JL; Wang, ZH; Xi, Y; Zhang, Q1
Byeon, SH; Chung, EJ; Koh, HJ; Lee, JH; Lim, HJ; Yoo, S1
Lee, YC; Park, YH; Roh, SY1
Kampik, A; Kernt, M; Neubauer, AS; Staehler, M; Stief, C1

Other Studies

5 other study(ies) available for sorafenib and Choroid Neovascularization

ArticleYear
Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
    International journal of molecular sciences, 2021, Apr-22, Volume: 22, Issue:9

    Topics: Administration, Ophthalmic; Animals; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Emulsions; Female; Male; Mice; Mice, Inbred C57BL; Nanostructures; Protein Kinase Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Neovascularization; Sorafenib

2021
Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib.
    Investigative ophthalmology & visual science, 2013, Dec-05, Volume: 54, Issue:13

    Topics: Animals; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Fundus Oculi; Humans; Liposomes; Male; Niacinamide; Oligopeptides; Phenylurea Compounds; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred BN; Receptors, Immunologic; Sorafenib; Vascular Endothelial Growth Factor A

2013
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
    The British journal of ophthalmology, 2009, Volume: 93, Issue:7

    Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Benzenesulfonates; Blotting, Western; Choroidal Neovascularization; Dextrans; Dose-Response Relationship, Drug; Female; Fluoresceins; Mice; Mice, Inbred C57BL; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib

2009
Effect of sorafenib on experimental choroidal neovascularization in the rat.
    Clinical & experimental ophthalmology, 2010, Volume: 38, Issue:7

    Topics: Animals; Benzenesulfonates; Choroidal Neovascularization; Computer Systems; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein Angiography; Gene Expression; Intercellular Adhesion Molecule-1; Lasers; Male; Niacinamide; Phenylurea Compounds; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyridines; Radiation Injuries; Rats; Rats, Inbred BN; Sorafenib; Vascular Endothelial Growth Factor A

2010
Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment.
    Acta ophthalmologica, 2008, Volume: 86, Issue:4

    Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Choroidal Neovascularization; Humans; Macular Edema; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib

2008